Institutional investors hold a majority ownership of EW through the 89.43% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended September 2014, these large investors purchased a net $57.6 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BMO ASSET MANAGEMENT, INC. Bought 133.6 Thousand shares of Edwards Lifesciences Corp
CANDRIAM BELGIUM SA Bought 90.8 Thousand shares of Edwards Lifesciences Corp